Furthermore, some authors observed that the expression levels of KMO and KYNU are potently upregulated in the course of HER2-enriched and triple-negative breast cancer subtypes, as well as cutaneous squamous cell carcinoma. The gene discussed is KYNU; the disease is cutaneous squamous cell carcinoma.